Inbox Robot - Choose newsletter content

Choose content

Enter keywords to create a newsletter

Create account

Enter your registration information

Set preferences

Set up your newsletter name, delivery and time zone preferences

Hint: Enter different keywords to generate new results.

Now you can:

Search the news index.
Browse more than 1 million newsletters by category.
Use preset newsletters:
- Reductase Inhibitors

Reductase Inhibitors Newsletter

Cycle Group Holdings Acquires Applied Therapeutics 03 Feb 2026 18:05 GMT
… nervous system (CNS) penetrant Aldose Reductase Inhibitor (ARI) for the treatment of …
Cycle Pharmaceuticals Completes Acquisition of Applied Therapeutics 03 Feb 2026 15:42 GMT
… nervous system (CNS) penetrant Aldose Reductase Inhibitor (ARI) for the treatment of …
“Absence of a widespread infectious disease emergency in 2025 has hindered progress in combating AMR” 31 Jan 2026 16:31 GMT
… are also developing investigational dihydrofolate reductase inhibitors aimed at drug-resistant Neisseria … ;D efforts for its dihydrofolate reductase inhibitors (DHFRIs) as a novel approach …
Doctor explains why your urine splits and goes everywhere which even 'she couldn't believe' 30 Jan 2026 18:25 GMT
… options, such as 'alpha reductase inhibitors', highlighting the importance of …
Applied Therapeutics Shares Letter to Stockholders Recommending Tender of Shares Following Offer Expiration Extension 29 Jan 2026 13:15 GMT
… nervous system (CNS) penetrant Aldose Reductase Inhibitor (ARI) for the treatment of …
Introducing the Sunday Times Tech 100: Life sciences part 2 27 Jan 2026 11:15 GMT
… its late-stage selective aldose reductase inhibitor, govorestat, for Charcot-Marie-Tooth …
Prostate-Specific Antigen Monitoring in Men Using 5-Alpha Reductase Inhibitors 25 Feb 2025 12:55 GMT
… prostate enlargement receiving 5-alpha reductase inhibitors: a non-interventional, … methodology, concerns about 5-alpha reductase inhibitors’ effects, biopsy triggers, … patients treated with 5-alpha reductase inhibitors. Source: bmcurol.biomedcentral.com …
The latest in clinical trial results of 5-alpha reductase inhibitors in combination regimens for benign prostatic hyperplasia. 13 Jan 2025 18:07 GMT
… fail conservative treatment. 5-alpha-reductase inhibitors (5-ARIs) is the only …
Testosterone and 5 Alpha Reductase Inhibitor (5ARI) in Benign Prostatic Hyperplasia (BPH): A historical perspective 17 Oct 2024 16:13 GMT
… Bowen, Testosterone and 5 Alpha Reductase Inhibitor (5ARI) in Benign Prostatic Hyperplasia …
Dutasteride, a 5 alpha reductase inhibitor, could be associated with the exacerbation of inflammation in patients with benign prostatic hyperplasia. 25 Oct 2024 09:04 GMT
α-1 blockers and dutasteride are widely used as agents to treat benign prostatic hyperplasia (BPH); the impact of these drugs on prostatic inflammation is still unclear. Herein, we investigated the impact of α-1 blockers and dutasteride treatment of BPH in …

Satisfied with the content?

Continue to create your account.

Choose content

Create account

Set preferences

EIN MARKETING SOLUTIONS

EIN NEWS SERVICES

ALL NEWS PUBLICATIONS